RTI-160
Chemical compound
| RTI-160 | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
RTI-160 is a chemical compound that belongs to the class of phenyltropanes, which are known for their stimulant properties. It is a cocaine analog that has been studied for its potential effects on the central nervous system.
Chemical Structure and Properties[edit]
RTI-160 is structurally related to cocaine, sharing the tropane ring system but differing in the substitution pattern on the phenyl ring. The compound is characterized by the presence of a 4-chlorophenyl group, which is a key feature distinguishing it from other phenyltropanes.

The IUPAC name for RTI-160 is Methyl (1R,2R,3S,5S)-3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate. This nomenclature reflects the stereochemistry of the molecule, which is crucial for its biological activity.
Pharmacology[edit]
RTI-160 acts primarily as a dopamine reuptake inhibitor, which means it blocks the reabsorption of dopamine into neurons, leading to increased levels of dopamine in the synaptic cleft. This mechanism is similar to that of cocaine, although RTI-160 may have different potency and selectivity profiles.
The compound has been studied in various animal models to assess its potential as a stimulant and its effects on behavior. These studies help in understanding the role of dopamine in the brain and the potential therapeutic applications or risks associated with dopamine reuptake inhibitors.
Potential Applications[edit]
Research into RTI-160 and related compounds is ongoing, with interest in their potential use in treating conditions such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. However, the potential for abuse and addiction remains a significant concern, as with other stimulants.
Safety and Toxicity[edit]
As with many psychoactive substances, the safety profile of RTI-160 is not fully understood. Studies typically focus on acute effects, but long-term effects and potential toxicity require further investigation. The presence of the 4-chlorophenyl group may influence the compound's metabolism and toxicity.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian